Medgenics Announces Public Offering of Common Stock
November 24, 2014 16:01 ET
|
Medgenics, Inc.
PHILADELPHIA, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The...
Medgenics Announces Rare & Orphan Disease Research Collaboration With The Children's Hospital of Philadelphia
November 12, 2014 16:01 ET
|
Medgenics, Inc.
Collaboration will bring together the premier pediatric genomics research organization, Center for Applied Genomics (CAG), with ex vivo gene therapy innovator, Medgenics, to discover and...
Medgenics Reports Positive Initial Clinical Data and Third Quarter Financial Results
October 15, 2014 08:00 ET
|
Medgenics, Inc.
Clinical proof of concept demonstrated with platform technology based on initial MDGN-201 results
Two commercial opportunities for MDGN-201 in orphan conditions identified
Pre-clinical...
Medgenics to Host Conference Call to Announce Third Quarter 2014 Results and Provide Initial Clinical Data on MDGN-201 on October 15, 2014
October 08, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, Oct. 8, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Wednesday, October 15, 2014 at 9 a.m. EDT to discuss...
Medgenics to Present Initial Clinical Data From MDGN-201 Study at European Society of Gene and Cell Therapy Congress
October 07, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic...
Medgenics to Announce Third Quarter 2014 Results and Provide Initial Clinical Data on MDGN-201 (EPODURE(TM)) Trial on October 15, 2014
September 24, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Wednesday, October 15, 2014 at 9 a.m. EDT to discuss...
Medgenics Announces the Appointment of Scott Applebaum as Chief Legal Officer
September 10, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, Sept. 10, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic...
Medgenics Reports Second Quarter Financial Results
July 16, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, July 16, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) (the Company), the developer of a novel platform technology for the sustained production and delivery...
Medgenics Announces Global Head, Research and Development, Garry Neil, M.D. Receives FDA Commissioner's Special Citation Award
June 18, 2014 20:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, June 18, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic...
Medgenics to Present at Two Upcoming Healthcare Investor Conferences
June 16, 2014 08:30 ET
|
Medgenics, Inc.
WAYNE, Pa. and MISGAV, Israel, June 16, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic...